Table 4.

Expression of proangiogenic factors and MVD according to the FIGO stage of ovarian cancer

	FIGO I and II (n = 24)	FIGO III and IV (n = 34)	P value
VEGF Median pg/mg protein (range, min–max)	270.35 (0–2,371.3)	610.35 (10.14–3,000.0)	0.134
EMMPRIN Median ng/mg protein (range, min–max)	26.52 (8.48–90.28)	37.55 (10.65–106.50)	0.013
bFGF Median ng/mg protein (range, min–max)	0.88 (0.27–13.32)	1.03 (0.17–8.33)	0.966
CD105-MVD Median vessels/mm2 (range, min–max)	16 (0–57)	25 (0–51)	0.203
CD31-MVD Median vessels/mm2 (range, min–max)	63 (25–203)	76 (19–241)	0.392
CD34-MVD Median vessels/mm2 (range, min–max)	57 (6–164)	82 (32–190)	0.171

CD105-MVD, CD31-MVD, and CD34-MVD refer to MVD assessed with antibodies against CD105, CD31, and CD34, respectively

Bold value is statistically significant (P < 0.05)